img

Global Spinal Biologics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Spinal Biologics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Spinal Biologics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Spinal Biologics market is projected to reach US$ 3906.8 million in 2034, increasing from US$ 2500 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2034. Demand from Hospitals and Spinal Surgery Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Spinal Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Spinal Biologics key manufacturers include Johnson & Johnson (Depuy Synthes), Orthofix Medical, Inc., Stryker Corporation, Zimmer Biomet, Arthrex, Inc., Exactech, Inc., Spine Wave, Inc., Medtronic plc and NuVasive, Inc., etc. Johnson & Johnson (Depuy Synthes), Orthofix Medical, Inc., Stryker Corporation are top 3 players and held % sales share in total in 2022.
Spinal Biologics can be divided into Minimally Invasive Surgery and Open Surgery, etc. Minimally Invasive Surgery is the mainstream product in the market, accounting for % sales share globally in 2022.
Spinal Biologics is widely used in various fields, such as Hospitals, Spinal Surgery Centers and Others,, etc. Hospitals provides greatest supports to the Spinal Biologics industry development. In 2022, global % sales of Spinal Biologics went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Spinal Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson (Depuy Synthes)
Orthofix Medical, Inc.
Stryker Corporation
Zimmer Biomet
Arthrex, Inc.
Exactech, Inc.
Spine Wave, Inc.
Medtronic plc
NuVasive, Inc.
Segment by Type
Minimally Invasive Surgery
Open Surgery

Segment by Application


Hospitals
Spinal Surgery Centers
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Spinal Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Spinal Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Spinal Biologics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Spinal Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Spinal Biologics introduction, etc. Spinal Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Spinal Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Spinal Biologics Market Overview
1.1 Spinal Biologics Product Overview
1.2 Spinal Biologics Market Segment by Type
1.2.1 Minimally Invasive Surgery
1.2.2 Open Surgery
1.3 Global Spinal Biologics Market Size by Type
1.3.1 Global Spinal Biologics Market Size Overview by Type (2024-2034)
1.3.2 Global Spinal Biologics Historic Market Size Review by Type (2024-2024)
1.3.3 Global Spinal Biologics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Spinal Biologics Sales Breakdown by Type (2024-2024)
1.4.2 Europe Spinal Biologics Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Spinal Biologics Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Spinal Biologics Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Spinal Biologics Sales Breakdown by Type (2024-2024)
2 Global Spinal Biologics Market Competition by Company
2.1 Global Top Players by Spinal Biologics Sales (2024-2024)
2.2 Global Top Players by Spinal Biologics Revenue (2024-2024)
2.3 Global Top Players by Spinal Biologics Price (2024-2024)
2.4 Global Top Manufacturers Spinal Biologics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Spinal Biologics Market Competitive Situation and Trends
2.5.1 Spinal Biologics Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Spinal Biologics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spinal Biologics as of 2022)
2.7 Date of Key Manufacturers Enter into Spinal Biologics Market
2.8 Key Manufacturers Spinal Biologics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Spinal Biologics Status and Outlook by Region
3.1 Global Spinal Biologics Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Spinal Biologics Historic Market Size by Region
3.2.1 Global Spinal Biologics Sales in Volume by Region (2024-2024)
3.2.2 Global Spinal Biologics Sales in Value by Region (2024-2024)
3.2.3 Global Spinal Biologics Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Spinal Biologics Forecasted Market Size by Region
3.3.1 Global Spinal Biologics Sales in Volume by Region (2024-2034)
3.3.2 Global Spinal Biologics Sales in Value by Region (2024-2034)
3.3.3 Global Spinal Biologics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Spinal Biologics by Application
4.1 Spinal Biologics Market Segment by Application
4.1.1 Hospitals
4.1.2 Spinal Surgery Centers
4.1.3 Others
4.2 Global Spinal Biologics Market Size by Application
4.2.1 Global Spinal Biologics Market Size Overview by Application (2024-2034)
4.2.2 Global Spinal Biologics Historic Market Size Review by Application (2024-2024)
4.2.3 Global Spinal Biologics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Spinal Biologics Sales Breakdown by Application (2024-2024)
4.3.2 Europe Spinal Biologics Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Spinal Biologics Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Spinal Biologics Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Spinal Biologics Sales Breakdown by Application (2024-2024)
5 North America Spinal Biologics by Country
5.1 North America Spinal Biologics Historic Market Size by Country
5.1.1 North America Spinal Biologics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Spinal Biologics Sales in Volume by Country (2024-2024)
5.1.3 North America Spinal Biologics Sales in Value by Country (2024-2024)
5.2 North America Spinal Biologics Forecasted Market Size by Country
5.2.1 North America Spinal Biologics Sales in Volume by Country (2024-2034)
5.2.2 North America Spinal Biologics Sales in Value by Country (2024-2034)
6 Europe Spinal Biologics by Country
6.1 Europe Spinal Biologics Historic Market Size by Country
6.1.1 Europe Spinal Biologics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Spinal Biologics Sales in Volume by Country (2024-2024)
6.1.3 Europe Spinal Biologics Sales in Value by Country (2024-2024)
6.2 Europe Spinal Biologics Forecasted Market Size by Country
6.2.1 Europe Spinal Biologics Sales in Volume by Country (2024-2034)
6.2.2 Europe Spinal Biologics Sales in Value by Country (2024-2034)
7 Asia-Pacific Spinal Biologics by Region
7.1 Asia-Pacific Spinal Biologics Historic Market Size by Region
7.1.1 Asia-Pacific Spinal Biologics Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Spinal Biologics Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Spinal Biologics Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Spinal Biologics Forecasted Market Size by Region
7.2.1 Asia-Pacific Spinal Biologics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Spinal Biologics Sales in Value by Region (2024-2034)
8 Latin America Spinal Biologics by Country
8.1 Latin America Spinal Biologics Historic Market Size by Country
8.1.1 Latin America Spinal Biologics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Spinal Biologics Sales in Volume by Country (2024-2024)
8.1.3 Latin America Spinal Biologics Sales in Value by Country (2024-2024)
8.2 Latin America Spinal Biologics Forecasted Market Size by Country
8.2.1 Latin America Spinal Biologics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Spinal Biologics Sales in Value by Country (2024-2034)
9 Middle East and Africa Spinal Biologics by Country
9.1 Middle East and Africa Spinal Biologics Historic Market Size by Country
9.1.1 Middle East and Africa Spinal Biologics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Spinal Biologics Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Spinal Biologics Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Spinal Biologics Forecasted Market Size by Country
9.2.1 Middle East and Africa Spinal Biologics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Spinal Biologics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Johnson & Johnson (Depuy Synthes)
10.1.1 Johnson & Johnson (Depuy Synthes) Company Information
10.1.2 Johnson & Johnson (Depuy Synthes) Introduction and Business Overview
10.1.3 Johnson & Johnson (Depuy Synthes) Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Johnson & Johnson (Depuy Synthes) Spinal Biologics Products Offered
10.1.5 Johnson & Johnson (Depuy Synthes) Recent Development
10.2 Orthofix Medical, Inc.
10.2.1 Orthofix Medical, Inc. Company Information
10.2.2 Orthofix Medical, Inc. Introduction and Business Overview
10.2.3 Orthofix Medical, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Orthofix Medical, Inc. Spinal Biologics Products Offered
10.2.5 Orthofix Medical, Inc. Recent Development
10.3 Stryker Corporation
10.3.1 Stryker Corporation Company Information
10.3.2 Stryker Corporation Introduction and Business Overview
10.3.3 Stryker Corporation Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Stryker Corporation Spinal Biologics Products Offered
10.3.5 Stryker Corporation Recent Development
10.4 Zimmer Biomet
10.4.1 Zimmer Biomet Company Information
10.4.2 Zimmer Biomet Introduction and Business Overview
10.4.3 Zimmer Biomet Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Zimmer Biomet Spinal Biologics Products Offered
10.4.5 Zimmer Biomet Recent Development
10.5 Arthrex, Inc.
10.5.1 Arthrex, Inc. Company Information
10.5.2 Arthrex, Inc. Introduction and Business Overview
10.5.3 Arthrex, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Arthrex, Inc. Spinal Biologics Products Offered
10.5.5 Arthrex, Inc. Recent Development
10.6 Exactech, Inc.
10.6.1 Exactech, Inc. Company Information
10.6.2 Exactech, Inc. Introduction and Business Overview
10.6.3 Exactech, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Exactech, Inc. Spinal Biologics Products Offered
10.6.5 Exactech, Inc. Recent Development
10.7 Spine Wave, Inc.
10.7.1 Spine Wave, Inc. Company Information
10.7.2 Spine Wave, Inc. Introduction and Business Overview
10.7.3 Spine Wave, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Spine Wave, Inc. Spinal Biologics Products Offered
10.7.5 Spine Wave, Inc. Recent Development
10.8 Medtronic plc
10.8.1 Medtronic plc Company Information
10.8.2 Medtronic plc Introduction and Business Overview
10.8.3 Medtronic plc Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Medtronic plc Spinal Biologics Products Offered
10.8.5 Medtronic plc Recent Development
10.9 NuVasive, Inc.
10.9.1 NuVasive, Inc. Company Information
10.9.2 NuVasive, Inc. Introduction and Business Overview
10.9.3 NuVasive, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2024-2024)
10.9.4 NuVasive, Inc. Spinal Biologics Products Offered
10.9.5 NuVasive, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Spinal Biologics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Spinal Biologics Industrial Chain Analysis
11.4 Spinal Biologics Market Dynamics
11.4.1 Spinal Biologics Industry Trends
11.4.2 Spinal Biologics Market Drivers
11.4.3 Spinal Biologics Market Challenges
11.4.4 Spinal Biologics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Spinal Biologics Distributors
12.3 Spinal Biologics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Minimally Invasive Surgery
Table 2. Major Company of Open Surgery
Table 3. Global Spinal Biologics Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Spinal Biologics Sales by Type (2024-2024) & (K Units)
Table 5. Global Spinal Biologics Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Spinal Biologics Sales by Type (2024-2024) & (US& Million)
Table 7. Global Spinal Biologics Market Share in Value by Type (2024-2024)
Table 8. Global Spinal Biologics Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Spinal Biologics Sales by Type (2024-2034) & (K Units)
Table 10. Global Spinal Biologics Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Spinal Biologics Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Spinal Biologics Sales Market Share in Value by Type (2024-2034)
Table 13. Global Spinal Biologics Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Spinal Biologics Sales by Type (2024-2024) & (K Units)
Table 15. North America Spinal Biologics Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Spinal Biologics Sales (K Units) by Type (2024-2024)
Table 17. Europe Spinal Biologics Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Spinal Biologics Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Spinal Biologics Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Spinal Biologics Sales (K Units) by Type (2024-2024)
Table 21. Latin America Spinal Biologics Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Spinal Biologics Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Spinal Biologics Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Spinal Biologics Sales by Company (2024-2024) & (K Units)
Table 25. Global Spinal Biologics Sales Share by Company (2024-2024)
Table 26. Global Spinal Biologics Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Spinal Biologics Revenue Share by Company (2024-2024)
Table 28. Global Market Spinal Biologics Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Spinal Biologics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Spinal Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spinal Biologics as of 2022)
Table 32. Date of Key Manufacturers Enter into Spinal Biologics Market
Table 33. Key Manufacturers Spinal Biologics Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Spinal Biologics Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Spinal Biologics Sales by Region (2024-2024) & (K Units)
Table 37. Global Spinal Biologics Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Spinal Biologics Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Spinal Biologics Sales Market Share in Value by Region (2024-2024)
Table 40. Global Spinal Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Spinal Biologics Sales by Region (2024-2034) & (K Units)
Table 42. Global Spinal Biologics Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Spinal Biologics Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Spinal Biologics Sales Market Share in Value by Region (2024-2034)
Table 45. Global Spinal Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Spinal Biologics Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Spinal Biologics Sales by Application (2024-2024) & (K Units)
Table 48. Global Spinal Biologics Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Spinal Biologics Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Spinal Biologics Sales Market Share in Value by Application (2024-2024)
Table 51. Global Spinal Biologics Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Spinal Biologics Sales by Application (2024-2034) & (K Units)
Table 53. Global Spinal Biologics Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Spinal Biologics Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Spinal Biologics Sales Market Share in Value by Application (2024-2034)
Table 56. Global Spinal Biologics Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Spinal Biologics Sales by Application (2024-2024) (K Units)
Table 58. North America Spinal Biologics Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Spinal Biologics Sales by Application (2024-2024) (K Units)
Table 60. Europe Spinal Biologics Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Spinal Biologics Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Spinal Biologics Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Spinal Biologics Sales by Application (2024-2024) (K Units)
Table 64. Latin America Spinal Biologics Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Spinal Biologics Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Spinal Biologics Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Spinal Biologics Sales by Country (2024-2024) & (K Units)
Table 68. North America Spinal Biologics Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Spinal Biologics Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Spinal Biologics Sales Market Share in Value by Country (2024-2024)
Table 71. North America Spinal Biologics Sales by Country (2024-2034) & (K Units)
Table 72. North America Spinal Biologics Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Spinal Biologics Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Spinal Biologics Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Spinal Biologics Sales by Country (2024-2024) & (K Units)
Table 76. Europe Spinal Biologics Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Spinal Biologics Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Spinal Biologics Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Spinal Biologics Sales by Country (2024-2034) & (K Units)
Table 80. Europe Spinal Biologics Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Spinal Biologics Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Spinal Biologics Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Spinal Biologics Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Spinal Biologics Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Spinal Biologics Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Spinal Biologics Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Spinal Biologics Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Spinal Biologics Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Spinal Biologics Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Spinal Biologics Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Spinal Biologics Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Spinal Biologics Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Spinal Biologics Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Spinal Biologics Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Spinal Biologics Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Spinal Biologics Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Spinal Biologics Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Spinal Biologics Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Spinal Biologics Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Spinal Biologics Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Spinal Biologics Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Spinal Biologics Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Spinal Biologics Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Spinal Biologics Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Spinal Biologics Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Spinal Biologics Sales Market Share in Value by Country (2024-2034)
Table 107. Johnson & Johnson (Depuy Synthes) Company Information
Table 108. Johnson & Johnson (Depuy Synthes) Introduction and Business Overview
Table 109. Johnson & Johnson (Depuy Synthes) Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Johnson & Johnson (Depuy Synthes) Spinal Biologics Product
Table 111. Johnson & Johnson (Depuy Synthes) Recent Development
Table 112. Orthofix Medical, Inc. Company Information
Table 113. Orthofix Medical, Inc. Introduction and Business Overview
Table 114. Orthofix Medical, Inc. Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Orthofix Medical, Inc. Spinal Biologics Product
Table 116. Orthofix Medical, Inc. Recent Development
Table 117. Stryker Corporation Company Information
Table 118. Stryker Corporation Introduction and Business Overview
Table 119. Stryker Corporation Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Stryker Corporation Spinal Biologics Product
Table 121. Stryker Corporation Recent Development
Table 122. Zimmer Biomet Company Information
Table 123. Zimmer Biomet Introduction and Business Overview
Table 124. Zimmer Biomet Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Zimmer Biomet Spinal Biologics Product
Table 126. Zimmer Biomet Recent Development
Table 127. Arthrex, Inc. Company Information
Table 128. Arthrex, Inc. Introduction and Business Overview
Table 129. Arthrex, Inc. Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Arthrex, Inc. Spinal Biologics Product
Table 131. Arthrex, Inc. Recent Development
Table 132. Exactech, Inc. Company Information
Table 133. Exactech, Inc. Introduction and Business Overview
Table 134. Exactech, Inc. Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Exactech, Inc. Spinal Biologics Product
Table 136. Exactech, Inc. Recent Development
Table 137. Spine Wave, Inc. Company Information
Table 138. Spine Wave, Inc. Introduction and Business Overview
Table 139. Spine Wave, Inc. Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Spine Wave, Inc. Spinal Biologics Product
Table 141. Spine Wave, Inc. Recent Development
Table 142. Medtronic plc Company Information
Table 143. Medtronic plc Introduction and Business Overview
Table 144. Medtronic plc Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Medtronic plc Spinal Biologics Product
Table 146. Medtronic plc Recent Development
Table 147. NuVasive, Inc. Company Information
Table 148. NuVasive, Inc. Introduction and Business Overview
Table 149. NuVasive, Inc. Spinal Biologics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. NuVasive, Inc. Spinal Biologics Product
Table 151. NuVasive, Inc. Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Spinal Biologics Market Trends
Table 155. Spinal Biologics Market Drivers
Table 156. Spinal Biologics Market Challenges
Table 157. Spinal Biologics Market Restraints
Table 158. Spinal Biologics Distributors List
Table 159. Spinal Biologics Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Spinal Biologics Product Picture
Figure 2. Global Spinal Biologics Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Spinal Biologics Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Spinal Biologics Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Minimally Invasive Surgery
Figure 6. Global Minimally Invasive Surgery Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Open Surgery
Figure 8. Global Open Surgery Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Spinal Biologics Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Spinal Biologics Sales Market Share by Type in 2022 & 2034
Figure 11. North America Spinal Biologics Sales Market Share in Volume by Type in 2022
Figure 12. North America Spinal Biologics Sales Market Share in Value by Type in 2022
Figure 13. Europe Spinal Biologics Sales Market Share in Volume by Type in 2022
Figure 14. Europe Spinal Biologics Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Spinal Biologics Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Spinal Biologics Sales Market Share in Value by Type in 2022
Figure 17. Latin America Spinal Biologics Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Spinal Biologics Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Spinal Biologics Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Spinal Biologics Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Spinal Biologics Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Spinal Biologics Revenue in 2022
Figure 23. Spinal Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Spinal Surgery Centers
Figure 27. Global Spinal Surgery Centers Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Spinal Biologics Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Spinal Biologics Sales Market Share by Application in 2022 & 2034
Figure 32. North America Spinal Biologics Sales Market Share in Volume by Application in 2022
Figure 33. North America Spinal Biologics Sales Market Share in Value by Application in 2022
Figure 34. Europe Spinal Biologics Sales Market Share in Volume by Application in 2022
Figure 35. Europe Spinal Biologics Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Spinal Biologics Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Spinal Biologics Sales Market Share in Value by Application in 2022
Figure 38. Latin America Spinal Biologics Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Spinal Biologics Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Spinal Biologics Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Spinal Biologics Manufacturing Cost Structure
Figure 43. Spinal Biologics Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed